| Contents |
|
| Description | CARTA GEN™ is an advanced regenerative peptide formulation containing Cartalax, a bioregulatory peptide studied for its role in supporting connective tissue health, cartilage function, and musculoskeletal wellness. Cartalax is designed to support natural tissue regeneration pathways by promoting healthy cellular activity within cartilage and connective tissues. It may help maintain joint structure, support mobility, and contribute to improved flexibility and physical resilience. By supporting cartilage health and balanced inflammatory response, CARTA GEN™ may be used in wellness protocols focused on joint comfort, connective tissue support, recovery from physical stress, and long-term musculoskeletal health. |
| Administration | Administer via Subcutaneous (SC) injection under the supervision of a qualified healthcare professional. |
| Storage |
|
| Dosage | Typical dosage: 2–3 mg per day. Dosage may be adjusted according to individual requirements, response, and professional guidance. Use under medical supervision. |
| Indication | CARTA GEN™ may be used in:
|
| Contraindications | Do not use CARTA GEN™ if:
|
| Special Precautions |
|
| Adverse Drug Reactions |
|
| Drug Interactions | Limited interaction data are available. Use cautiously with:
|
| Disclaimer | Images shown on the website are for representation purposes only and may differ from the actual product. Packaging designs may change without prior notice. Use only under professional medical supervision. |